The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance-Reference-Cited by-同舟云学术

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance

Published:2016-04-07 Issue:19 Volume:7 Page:28273-28285
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Quackenbush Kevin S.¹,Bagby Stacey¹,Tai Wai Meng¹²,Messersmith Wells A.¹,Schreiber Anna¹,Greene Justin¹,Kim Jihye¹,Wang Guoliang¹,Purkey Alicia¹,Pitts Todd M.¹,Nguyen Anna¹,Gao Dexiang¹,Blatchford Patrick¹,Capasso Anna¹,Schuller Alwin G.³,Eckhardt S. Gail¹,Arcaroli John J.¹

Affiliation:

1. Division of Medical Oncology, University of Colorado Denver and University of Colorado Cancer Center, Denver, CO, USA

2. Division of Medical Oncology, National Cancer Centre Singapore, Singapore

3. AstraZeneca R & D Boston, Massachusetts, Waltham, Massachusetts, MA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy;Journal of Hematology & Oncology;2024-06-18

2. PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer;Expert Opinion on Therapeutic Targets;2024-03-03

3. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells;British Journal of Cancer;2023-11-15

4. 2D-QSAR, Molecular Docking, and in silico Pharmacokinetics Analysis on N-substituted Urea and Thiourea Derivatives as Tankyrase Inhibitors for Implication in Cancer;Indian Journal of Pharmaceutical Education and Research;2023-07-23

5. ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer;BMC Cancer;2022-10-29